Excess risk of cardiovascular events in RA patients decreased since start of 21st century

June 16, 2017, European League Against Rheumatism

The results of a meta-analysis presented for the first time today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that the excess risk of cardiovascular events in rheumatoid arthritis (RA) patients relative to the general population has decreased since the year 2000.

Compared with the general population, RA patients are known to have an increased risk of cardiovascular disease or events, including stroke, Myocardial Infarction (MI), Congestive Heart Failure (CHF) and Cardiovascular Mortality (CVM).

This new analysis has confirmed the increased risk of among people with RA relative to the general population. However, the excess risk appears to be less prevalent than prior to the year 2000.

"This reduction in may have two explanations," said Elisabeth Filhol, a rheumatologist in training at Nîmes University Hospital, France. "It may simply be due to better management of cardiovascular risk in patients with RA."

"However, knowing that is the cornerstone of both RA and atherosclerosis, it may also be related to better control of chronic systemic inflammation as the result of new therapeutic strategies," speculated Professor Cécile Gaujoux-Viala of the University of Montpellier, head of the department of rheumatology of the Nîmes University Hospital and senior investigator on the study.

"Over the past fifteen years, new treatment strategies such as tight control, treat to target, methotrexate optimisation, and the use of biologic DMARDs has allowed a better control of systemic inflammation in patients with RA," Professor Gaujoux-Viala added.

To assess the excess risk of presenting a cardiovascular event in RA patients compared to the , before and after the 2000s, a detailed literature search was conducted that included PubMed and Cochrane Library up until March 2016.

Out of 5,714 screened references, 28 observational studies that provided data on the occurrence of a cardiovascular event (stroke, MI, CHF, CVM) in patients with RA and in a control group were eligible. A meta-analysis of relative risk (RR) concerning patients with RA in relation to the control group was performed for each cardiovascular event and for each period (before and after the 2000s).

For studies published before 2000, a highly significant increase in the risk of all four was observed in RA patients vs. controls as follows: RR=1.12, [95 % CI 1.04; 1.21], p=0.002 for stroke, RR=1.25 [1.14; 1.37], p<0.00001 for CHF, RR=1.21 [1.15; 1.26], p<0.00001 for CVM ,and RR=1.32 [1.24; 1.41], p<0.00001) for MI.

For all studies published after the year 2000, the increased cardiovascular risk was not related to CHF and CVM (RR= 1.17 [0.88; 1.56], p=0.27 and RR=1.07 [0.74; 1.56], p=0.71 respectively). The excess risk of MI was reduced in comparison with the period before 2000: RR=1.18 [1.14; 1.23], (p<0.00001), and the excess risk of stroke remained stable (p=0.006).

Explore further: Genes explain higher prevalence of CVD in chronic IMID patients

Related Stories

Genes explain higher prevalence of CVD in chronic IMID patients

June 16, 2017
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 represent an important step towards characterising the genetic basis of cardiovascular disease (CVD) risk in chronic immune-mediated ...

Non-O blood groups associated with higher risk of heart attack

April 30, 2017
Having a non-O blood group is associated with a higher risk of heart attack, according to research presented today at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure.

Cardiovascular event risk of RA patients comparable to type-2 diabetes over 15-year period

November 13, 2016
Rheumatoid arthritis is associated with serious risk of cardiovascular (CV) disease events such as heart attack or stroke. Over a 15-year period, people with RA may have double the risk of CV events as those in the general ...

Hidradenitis suppurativa and risk of adverse cardiovascular events, death

February 17, 2016
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease marked by painful abscesses that develop in areas where there are large numbers of sweat glands. These ooze pus and have an unpleasant smell. The disease ...

Treatment with anti-TNFs reduces the risk of cardiovascular events in rheumatoid arthritis

June 7, 2012
Results from a retrospective analysis of contemporary data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, predict, based on estimates from a multivariate regression model, that ...

Sorafenib, sunitinib may pose cardiovascular risk

October 13, 2015
(HealthDay)—Older kidney cancer patients treated with sorafenib or sunitinib may face an increased risk of cardiovascular adverse events, according to a study published online Oct. 6 in Cancer.

Recommended for you

Changing how blood pressure is measured will save lives

April 19, 2018
Traditional methods of testing for high-blood pressure are no longer adequate and risk missing vital health signs, which can lead to premature death, a study co-led by UCL has found.

Eyes of adolescents could reveal risk of cardiovascular disease

April 19, 2018
New research has found that poorer well-being or 'health-related quality of life' (HRQoL) in adolescence could be an indicator of future cardiovascular disease risk.

Obesity linked with higher chance of developing rapid, irregular heart rate

April 18, 2018
People with obesity are more likely to develop a rapid and irregular heart rate, called atrial fibrillation, which can lead to stroke, heart failure and other complications, according to Penn State researchers.

Comparing strategies to guide blood pressure treatment

April 18, 2018
A strategy that examines a patient's overall heart disease and stroke risk to determine blood pressure treatment—rather than blood pressure levels alone—is more effective at preventing events like heart attacks, strokes ...

Using AI to detect heart disease

April 17, 2018
Heart disease is the leading cause of death for both men and women, according to the Centers for Disease Control and Prevention (CDC). In the U.S., one in every four deaths is a result of heart disease, which includes a range ...

Antioxidant therapy may reduce cardiovascular risk of young women with type 1 diabetes

April 17, 2018
The high estrogen levels that typically afford younger women protection from cardiovascular disease appear to instead multiply their risk if they have type 1 diabetes, researchers say.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.